Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.44% shed 0.63% to $157.09 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -1.84% rising 1.42% to 4,577.10 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.51% rising 1.82% to 34,639.79. Johnson & Johnson closed $22.83 below its 52-week high ($179.92), which the company reached on August 20th.
Despite its losses, the stock outperformed some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -0.52% fell 1.52% to $393.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.20% fell 0.74% to $73.89, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -1.53% fell 3.00% to $53.04.true Trading volume (11.2 M) eclipsed its 50-day average volume of 6.9 M.